From: Neuromyelitis optica spectrum disorders with and without connective tissue disorders
SS(7) | UCTD (7) | SLE(3) | RA(1) | |
---|---|---|---|---|
Gender, n (% female) | 7 (100%) | 7 (100%) | 3 (100%) | 1 (100%) |
Age at onset, years | 41.29 ± 11.73 | 39.29 ± 9.07 | 40.67 ± 11.15 | 45.0 ± 0 |
Follow-up duration, years | 6.07 ± 4.44 | 5.54 ± 3.79 | 2.51 ± 1.96 | 2.0 ± 0 |
Annualized relapse rate (ARR) | 1.87 ± 2.36 | 0.92 ± 0.51 | 1.40 ± 0.45 | 1.5 ± 0 |
neuropathic pain, n (%) | 3 (30%) | 6 (60%) | 1 (10%) | 0 (0%) |
Number of attacks | 5.29 ± 2.69 | 3.71 ± 1.70 | 3.67 ± 3.06 | 3.0 ± 0 |
EDSS at nadir | 5.29 ± 2.84 | 4.21 ± 1.82 | 6.17 ± 2.36 | 3.0 ± 0 |
EDSS at last follow-up | 4.07 ± 2.99 | 2.21 ± 0.57 | 4.17 ± 2.47 | 2.0 ± 0 |
Initial presentation, n (%) | ||||
ON | 2 (28.57%) | 2 (28.57%) | 1 (33.33%) | 1 (100%) |
Area postrema syndrome | 2 (28.57%) | 0 (0%) | 0 (0%) | 0 (0%) |
AM | 2 (28.57%) | 5 (71.43%) | 2 (66.67%) | 0 (0%) |
Others | 1 (14.29%) | 0 (0%) | 0 (0%) | 0 (0%) |